文献速递先天性心脏病外科

双出口右心室双心室修复远期结局的多中心研究

Multicentre study on late outcomes of biventricular repair of double outlet right ventricle.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

这项回顾性多中心研究分析了来自新兴国家的81例双出口右心室(DORV)患儿在法国9家儿童心脏外科医院接受双心室修复的远期结局。围手术期死亡率为7.4%±2.6%(6/81,95%CI 2.8%-15.4%),10年总生存率为86%;DORV-非限制性室间隔缺损(ncVSD)与限制性室间隔缺损(committed VSD)的早期死亡率相似(5.9%±2.4% vs 7.8%±2.7%,P=0.79)。

要点

  • 81例DORV双心室修复的围手术期死亡率为7.4%±2.6%(6/81,95%CI 2.8%-15.4%)。
  • 10年总生存率为86%。
  • DORV-ncVSD与DORV-committed VSD早期死亡率相似(5.9%±2.4% vs 7.8%±2.7%,P=0.79)。

核心结论

  • 10年总生存率为86%。
  • 本研究表明,与复杂DORV伴ncVSD相比,简单DORV伴committed VSD的双心室修复在早期和晚期结局方面呈现满意趋势。

研究设计与样本

  • 回顾性多中心研究,纳入1996年1月至2022年1月期间在法国9家儿童心脏外科医院接受DORV双心室修复的81例连续患儿。
  • 患儿由Mécénat Chirurgie Cardiaque从新兴国家转送至法国手术,数据来自该机构综合数据库并严格术后随访。
  • 纳入标准为具有2个可存活心室并接受双心室修复的DORV患者;排除4例Fontan患者。
  • DORV定义为根据国际疾病分类第十一次修订本,两条大动脉完全或主要起源于形态学右心室。

主要发现

  • 围手术期总死亡率为7.4%±2.6%,6/81(95%CI 2.8%-15.4%),范围从DORV-AVSD-PS的0%到DORV-ncVSD-no PS的14%。
  • 10年总生存率为86%。
  • DORV-ncVSD早期死亡率为5.9%±2.4%(1/17),DORV-committed VSD为7.8%±2.7%(5/64),两者相似(P=0.79)。
  • VSD扩大在DORV-ncVSD中显著更常见,为42%(5/12)(P=0.001)。
  • 动脉调转术和DORV-AVSD-PS修复呈现最佳结局趋势;复杂组病例数少,Fontan病例数明显偏低。

关键数值与推荐

  • DORV分为6个亚型:DORV-committed VSD组包括DORV-VSD(n=25)、DORV-Fallot(n=34)、DORV-转位大动脉(n=5);DORV-ncVSD组包括DORV-ncVSD-无肺动脉狭窄(PS)(n=7)、DORV-ncVSD-PS(n=5)、DORV-AVSD-PS(n=5)。
  • 3例失访(3.4%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 复杂组病例数少。
  • Fontan病例数明显偏低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The goal of this retrospective multicentre study was to present late surgical outcomes of the treatment of children with double outlet right ventricle (DORV) coming from emerging countries. METHODS: The Mécénat Chirurgie Cardiaque brings to France for surgery selected children with simple and complex congenital diseases, including DORV. The patients are operated on in 9 hospitals that specialize in paediatric cardiac surgery. Data are collected from the Mécénat Chirurgie Cardiaque comprehensive database, with a strict postoperative follow-up. The patients included only those who had biventricular repair of DORV with 2 viable ventricles. According to the classification of the Eleventh Revision of the International Classification of Diseases, DORV was defined as a congenital cardiovascular malformation in which both great arteries arise entirely or predominantly from the morphologically right ventricle. RESULTS: From January 1996 to January 2022, a total of 81 consecutive DORV biventricular repair operations were performed. There were 6 subtypes of DORV divided into 2 groups: DORV-committed ventricular septal defect (VSD): DORV-VSD (n = 25), DORV-Fallot (n = 34), DORV-transposition of the great arteries (n = 5); and DORV-non-committed (nc) VSD: DORV-ncVSD-no pulmonary stenosis (PS) (n = 7), DORV-ncVSD-PS (n = 5) and DORV-atrioventricular septal defect (AVSD)-PS (n = 5). Four Fontan patients were excluded. Three patients were lost to follow-up (3.4%). The overall perioperative mortality was 7.4% ± 2.6%, 6/81 (95% confidence interval: 2.8%-15.4%) ranging from 0% in DORV-AVSD-PS to 14% for DORV-ncVSD-no PS. The overall 10-year survival was 86%. The early mortality of DORV-ncVSD at 5.9% ± 2.4% (1/17) was similar to that of DORV-committed VSD at 7.8% ± 2.7% (5/64) (P = 0.79). There was a trend towards an optimal outcome for the arterial switch operation and the DORV-AVSD-PS repair. VSD enlargement was significantly more frequent in DORV-ncVSD at 42% (5/12) (P = 0.001). There were low numbers in the complex groups. The number of Fontan cases was noticeably low. The aorta located entirely on the right ventricle represents the fundamental anomaly and the surgical challenge of DORV. CONCLUSIONS: Overall survival at 10 years was 86%. This study shows a trend towards satisfactory early and late outcomes in BVR of simple DORV with committed VSD, compared to complex DORV with ncVSD.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Lacour-Gayet F, Zoghbi J, Gouton M, et al. Multicentre study on late outcomes of biventricular repair of double outlet right ventricle. Eur J Cardiothorac Surg. 2024. PMID: 38134423. doi:10.1093/ejcts/ezad423

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。